This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wiviott, S. D. Articles by Braunwald, E. Search for Related Content PubMed PubMed Citation Articles by Wiviott, S. D. Articles by Braunwald, E.

Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4

A simple index that predicts mortality in ST-segment elevation myocardial infarction

Stephen D. Wiviott, MD^*,,*, David A. Morrow, MD, MPH^*,, Paul D. Frederick, MPH, MBA, Robert P. Giugliano, SM, MD^*,, C.Michael Gibson, MS, MD^*,, Carolyn H. McCabe, BS^*,, Christopher P. Cannon, MD^*,, Elliott M. Antman, MD^*, and Eugene Braunwald, MD^*,

^* TIMI Study Group
Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA
Ovation Research, Seattle, Washington, USA
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

View larger version (16K): [in a new window]   Figure 1 Distribution of patients (%) in risk score categories. Lines with diamonds = Intravenous nPA for Treatment of Infarcting Myocardium Early (InTIME-II) trial; lines with circles = ST-segment elevation myocardial infarction (STEMI)-reperfusion therapy (RT); and lines with triangles = STEMI–no RT.

View larger version (23K): [in a new window]   Figure 2 (A) Mortality (%) versus risk index in National Registry of Myocardial Infarction (NRMI) patients with ST-segment elevation myocardial infarction (STEMI). HR = heart rate; SBP = systolic blood pressure. (B) Risk index categories versus mortality in Intravenous nPA for Treatment of Infarcting Myocardium Early (InTIME-II) trial (open bars) versus NRMI STEMI-reperfusion therapy (solid bars).